The Study of Qishenyiqi Drop Pills in Improving the Prognosis of Heart Failure Patients
Status:
Unknown status
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, placebo-controlled study including patients
with ejection fraction decreased heart failure under standardized treatment, to evaluate
QiShenYiQi (QSYQ) dropping pill's curative effect in reducing cardiovascular death and heart
failure rehospitalization compared with placebo.
Phase:
Phase 4
Details
Lead Sponsor:
Chinese Academy of Medical Sciences, Fuwai Hospital